Current developments in SELDI affinity technology

Mass Spectrometry Reviews

Volumn 23, Issue 1, 2004, Pages 34-44

  Tang, Ning ^a   Tornatore, Pete ^a   Weinberger, Scot R ^a  

^a CIPHERGEN BIOSYSTEMS INC   (United States)

Author keywords

ProteinChip; SELDI; SEND; Surface enhanced laser desorption ionization

Indexed keywords

PROTEIN CHIPS; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION (SELDI);

AFFINITY CHROMATOGRAPHY; AMPLIFICATION; ANTIBODIES; BLOOD; CHEMICAL MODIFICATION; DESORPTION; DISEASES; EXTRACTION; HYDROPHOBICITY; IONIZATION; MASS SPECTROMETRY; PROBES; PURIFICATION; SELF ASSEMBLY;

PROTEINS;

PROTEIN;

CHEMISTRY; GENETIC PROCEDURES; MASS SPECTROMETRY; METHODOLOGY; MOLECULAR PROBE; PROTEIN MICROARRAY; REVIEW; SYNTHESIS;

MOLECULAR PROBE TECHNIQUES; MOLECULAR PROBES; PROTEIN ARRAY ANALYSIS; PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0142143227     PISSN: 02777037     EISSN: None     Source Type: Journal    
DOI: 10.1002/mas.10066     Document Type: Review

References (73)

1. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes JO, Schellhammer PF, Yasui Y, Feng Z, Wright GL, Jr. 2002. Serum protein fingerprinting coupled with a pattern-matching algorith distinguishes prostate cancer from benign prostate hyperplasia and healthy men: Cancer Res 62:3609-3614.
2. Austen B, Frears ER, Davies H. 2000. The use of Seldi ProteinChip® arrays to monitor production of Alzheimer's beta-amyloid in transfected cells. J Pept Sci Sep 6:459-460.
3. Austen B, Davies H, Stephens DJ, Fears ER, Walters CE. 1999. The role of cholesterol in the biosynthesis of beta-amyloid. Neuroreport 10:1699-1705.
4. Bai J, Qian MG, Liu Y, Liang X, Lubman DM. 1995. Peptide mapping by CNBr degradation on a nitrocellulose membrane with analysis by matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem 67: 1705-1710.
5. Bandera CA, Ye B, Mok SC. 2003. New technologies for the identification of markers for early detection of ovarian cancer. Curr Opin Obstet Gynecol 15:51-55.
6. Bane TK, LeBlanc JF, Lee TD, Riggs AD. 2002. DNA affinity capture and protein profiling by SELDI-TOF mass spectrometry: Effect of DNA methylation. Nucleic Acids Res 30:e69/1-e69/6.
7. Batorfi J, Ye B, Mok SC, Cseh I, Berkowitz RS, Fulop V. 2003. Protein profiling of complete mole and normal placenta using ProteinChip analysis on laser capture microdissected cells. Gynecol Oncol 88:424-428.
8. Berkowitz O, Wirtz M, Wolf A, Kuhlmann J, Hell R. 2002. Use of bimolecular interaction analysis to elucidate the regulatory mechanism of the cysteine synthase complex from Arabidopsis Thaliana. J Biol Chem 277:30629-30634.
9. Bischoff SR, Kahn MB, Powerll MD, Kirlin WG. 2002. SELDI-TOF-MS analysis of transcriptional activation protein binding to response elements regulating carcinogenesis enzymes. Int J Mol Sci 3:1027-1038.
10. Blackledge JA, Alexander AJ. 1995. Polyethylene membrane as a sample support for direct matrix-assisted laser desorption/ionization mass spectrometric analysis of high mass proteins. Anal Chem 67:843-848.
11. Brockman AH, Orlando R. 1994. New immobilization chemistry for probe affinity mass spectrometry. Rapid Commun Mass Spectrom 10:1688-1692.
12. Brockman AH, Orlando R. 1995. Probe-immobilized affinity chromatography/mass spectrometry. Anal Chem 67:4581-4585.
13. Bundy J, Fenselau C. 1999. Lectin-based affinity capture for MALDI-MS analysis of bacteria. Anal Chem 71:1460-1463.
14. Bundy J, Fenselau C. 2001. Lectin and carbohydrate affinity capture surfaces for mass spectrometric analysis of microorganisms. Anal Chem 73:751-757.
15. Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, Wong PC. 2001. BACE1 is the major beta-secretase for generation of abeta peptides by neurons. Nat Neurosci 4:233-234.
16. Chorev M, Suva LJ, Nakamoto C, Yang QM, Rashti-Behar V, Adams AE, Chin KR. 1995. Approaches to studying the biomolecular interaction between the parathyroid hormone/parathyroid hormone-related protein receptor and its ligands. Miner Electrolyte Metab 21:133-139.
17. Cleverly S, Bengio S, Boschetti E, Spencer J. 2003. Direct "OnChip" protein-expression monitoring. Genet Eng News 23:48-50.
18. Davies H, Lomas L, Austen B. 1999. Profiling of amyloid beta peptide variants using SELDI protein chip arrays. BioTechniques 27:1258-1261.
19. Diamond DL, Kimball JR, Krisanaprakornkit S, Ganz T, Dale BA. 2001. Detection of beta-defensins secreted by human oral epithelial cells. J Immunol Methods 256:65-76.
20. Fetsch PA, Simone NL, Bryant-Greenwood PK, Marincola FM, Filie AC, Petricoin EF, Liotta LA, Abatti A. 2002. Proteomic evaluation of archival cytologic material using SELDI affinity mass spectrometry. Am J Clin Pathol 118:870-876.
21. Harris RA, Yang A, Stein RC, Lucy K, Brusten L, Herath A, Parekh R, Waterfield MD, O'Hare MJ, Neville MA, Page MJ, Zvebil MJ. 2002. Cluster analysis of an extensive human breast cancer cell line protein expression map database. Proteomics 2:212-223.
22. Hillenkamp F, Strupat K, Karas M, Eckerskorn C, Lottspeich F. 1994. Matrix-assisted laser desorption ionization mass spectrometry of proteins electroblotted after polyacrylamide gel electrophoresis. Anal Chem 66:464-470.
23. Hinshelwood J, Spencer DIR, Edwards Y, Perkins SJ. 1999. Identification of the C3b binding site in a recombinant vWFA domain of complement factor B by surface-enhanced laser desorption-ionization affinity mass spectrometry and homology modelling: Implications for the activity of factor B. J Mol Biol 294:587-599.
24. Hogstrand C, Balesaria S, Glover CN. 2002. Application of genomics and proteomics for study of the integrated response to zinc exposure in a non-model fish species, the rainbow trout. Comp Biochem Physiol B 133:523-535.
25. Hutchens TW, Yip TT. 1992. Synthetic metal-binding protein surface domains for metal ion-dependent interaction chromatography. J Chromatogr 604:133-141.
26. Hutchens TW, Yip TT. 1993. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 7:576-580.
27. Hutchens TW, Yip TT. 1998. Method and apparatus for desorption and ionization of analytes, U.S. PTO, U.S. Baylor College of Medicine. 64 p.
28. Karas M, Bahr U, Ingendoh A, Nordhoff E, Stahl B, Strupat K, Hillenkamp F. 1990. Principles and applications of matrixassisted UV-laser desorption/ionization mass spectrometry. Anal Chim Acta 241:175-185.
29. Kuwata H, Yip TT, Tomita M, Hutchens TW. 1998a. Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin. Biochim Biophys Acta 1429:129-141.
30. Kuwata H, Yip T-T, Tomita M, Hutchens TW. 1998b. Bactericidal domain of lactoferrin: Detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. Biochem Biophys Res Commun 245:764-773.
31. Li YM, Lai MT, Xu M, Huang D, Muzio-Mower J, Saradana MK, Shi XP, Yin KC, Shafer JA, Gardell SJ. 2000. Presenilin 1 is linked with secretase activity in the detergent solubilized state. Proc Natl Acad Sci USA 23(97):6138-6143.
32. Li J, Zhang Z, Rosenzweig R, Wang YY, Chan DW. 2002. Proteomics and bioinformatics approached for identification of serum biomarkers to detecting breast cancer. Clin Chem J 48:1296-1304.
33. Liang X, Lubman DM, Rossi DT, Nordblom GD, Barksdale CM. 1998. On-probe immunoaffinity extraction by matrixassisted laser desorption/ionization mass spectrometry. Anal Chem 70:498-503.
34. Lin S, Tornatore P, King D, Orlando R, Weinberger SR. 2001. Limited acid hydrolysis as a means of fragmenting proteins isolated upon ProteinChip array surfaces. Proteomics 1:1172-1184.
35. Liotta LA, Kohn EC, Petricoin EF. 2001. Clinical proteomics: Personalized molecular medicine. J Am Med Assoc 286: 2211-2214.
36. Merchant M, Weinberger SR. 2000. Recent advancements in surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Electrophoresis 21:1164-1177.
37. Mock KK, Sutton CW, Cottrell JS. 1992. Sample immobilization protocols for matrix-assisted laser-desorption mass spectrometry. Rapid Commun Mass Spectrom 6: 233-238.
38. Nedelkov D, Nelson RW. 2000. Practical considerations in BIA/MS: Optimizing the biosensor-mass spectrometry interface. J Mol Recog 13:140-145.
39. Nedelkov D, Nelson RW. 2001a. Analysis of human urine protein biomarkers via biomolecular interaction analysis mass spectrometry. Am J Kidney Dis 38:481-487.
40. Nedelkov D, Nelson RW. 2001b. Analysis of native proteins from biological fluids by biomolecular interaction analysis mass spectrometry (BIA/MS): Exploring the limit of detection, identification of non-specific binding and detection of multiprotein complexes. Biosens Bioelectron 16:1071-1078.
41. Nedelkov D, Nelson RW. 2002. Biomolecular interaction analysis mass spectrometry (BIA/MS): Mass spectrometry and hyphenated techniques. In Neuropeptide research. New York: John Wiley & Sons, Inc. 19 p.
42. Nelson RW. 1997. The use of bioreactive probes in protein characterization. Mass Spectrom Rev 16:353-376.
43. Nelson RW, Nedelkov D, Tubbs KA. 2000a. Biomolecular interaction analysis mass spectrometry. Anal Chem 72: 404A-411A.
44. Nelson RW, Nedelkov D, Tubbs KA. 2000b. Biosensor chip mass spectrometry: A chip-based proteomics approach. Electrophoresis 21:1155-1163.
45. Nelson RW, Krone JR, Bieber AL, Williams P. 1995. Mass spectrometric immunoassay. Anal Chem 67:1153-1158.
46. Oren D, Li Y, Volovik Y, Morris TS, Dharia C, Das K, Galperina O, Gentz R, Arnold E. 2002. Structural basis of BLyS receptor recognition. Nat Struct Biol 9:288-292.
47. Papac DI, Hoyes J, Tomer KB. 1994. Direct analysis of affinitybound analytes by MALDI/TOF MS. Anal Chem 66:2609-2613.
48. Pei RJ, Cui XQ, Yang XR, Wang EK. 2002. Amplified immunoassay of human IgG using real-time biomolecular interaction analysis (BIA) technology. Chin J Chem 20: 441-446.
49. Petricoin EF, Ardenkani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA. 2002a. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359:572-577.
50. Petricoin EF, Ornstein DK, Paweletz CP, Ardenkani AM, Hackett PS, Hitt BA, Velassco A, Trucco C, Wiegand L, Wood K, Simone C, Charles B, Levine PJ, Linehan W, Marston EB, Michael R, Steinberg SM, Kohn EC, Liotta LA. 2002b. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 94:1576.
51. Petricoin EF, Zoon KC, Kohn EC, Barrett JC, Liotta LA. 2002c. Clinical proteomics: Translating benchside promise into bedside reality. Nat Rev Drug Discov 1:683-695.
52. Qu Y, Adam BL, Yasui Y, Ward MD, Cazares LH, Schellhammer PF, Paul F, Feng Z, Semmes JO, Wright GL, Jr. 2002. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin Chem 48:1835-1843.
53. Raska CS, Parker CE, Dominski Z, Marzluff WF, Glish GL, Pope MR, Borchers CH. 2002. Direct MALDI-MS/MS of phosphopeptides affinity-bound to immobilized metal ion affinity chromatography beads. Anal Chem 74:3429-3433.
54. Schenone MM, Warder SE, Martin JA, Prorok M, Castellino FJ. 2000. An internal histidine residue from the bacterial surface protein, PAM, mediates its binding to the kringle-2 domain of human plasminogen. J Pept Res 56:438-45.
55. Schriemer DC, Li L. 1996. Combining avidin-biotin chemistry with matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem 68. 3382-3387.
56. Slonim DK. 2002. From patterns to pathways: Gene expression data analysis comes of age. Nat Genet Suppl 32:502-508.
57. Talapatra A, Rouse R, Hardiman G. 2002. Protein microarrays: Challenges and promises. Pharmacogenomics 3:527-536.
58. Terai K, Iwai A, Kawabata S, Tasaki Y, Watanabe T, Miyata K, Yamaguchi T. 2001. β-Amyloid deposits in transgenic mice expressing human β-amyloid precursor protein have the same characteristics as those in Alzheimer's disease. Neuroscience 104:299-310.
59. Tseng K, Wang H, Lebrilla CB, Bonnell B, Hedrick J. 2001. Identification and structural elucidation of lectin-binding oligosaccharides by bioaffinity matrix-assisted laser desorption/ionization fourier transform mass spectrometry. Anal Chem 73:3556-3561.
60. Uchida T, Fukawa A, Uchida M, Fujita K, Saito K. 2002. Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid. J Proteome Res 1:495-499.
61. Vestling MM, Fenselau C. 1994. Poly(vinylidene difluoride) membranes as the interface between laser desorption mass spectrometry, gel electrophoresis, and in situ proteolysis. Anal Chem 66:471-477.
62. Wang H, Tseng K, Lebrilla CB. 1999. A general method of producing bioaffinity MALDI probes. Anal Chem 71:2014-2020.
63. Wang R, Sweeny D, Gandy SE, Sisodia SS. 1996. The profile of soluble amyloid β protein in cultured cell media: Detection and quantification of amyloid β protein and variants by immunoprecipitation mass spectrometry. J Biol Chem 271:31894-31902.
64. Weinberger SR, Dalmasso EA, Fung ET. 2001. Current achievements using ProteinChip array technology. Curr Opin Chem Biol 6:86-91.
65. Weinberger SR, Morris TS, Pawlak M. 2000. Recent trends in protein biochip technology. Pharmacogenomics 1:1462-2416.
66. Weinberger SR, Boschetti E, Santambien P, Brenac V. 2002. Surface-enhanced laser desorption/ionization retentate chromatography mass spectrometry (SELDI-RC-MS): A new method for rapid development of process chromatography conditions. J Chromatogr B 782:307-316.
67. Wishart DS, Fortin S. 2001. The biotools suite: A comprehensive suite of platform-independent bioinformatics tools. Mol Biotechnol 19:59-77.
68. Worrall TA, Cotter RJ, Woods AS. 1998. Purification of contaminated peptides and proteins on synthetic membrane surfaces for matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem 70:750-756.
69. Wright GL. 2002. SELDI Proteinchip MS: A platform for biomarker discovery and cancer diagnosis. Exp Rev Mol Diagn 2:549-563.
70. Xiang Z, Ho L, Yemul S, Zhao Z, Pompl P, Kelley K, Dang A, Qing W, Teplow D, Pasinetti GM. 2002. Cyclooxygenase-2 promotes amyloid plaque deposition in a mouse model of Alzheimers disease neuropathology. Gene Expr 10. 271-278.
71. Xiao Z, Adam BL, Caseres LH, Clements MA, Davis JW, Schlammer PF, Dalmasso EA, Wright GL, Jr. 2001. Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immuoassay discriminates benign from malignant prostate disease. Cancer Res 16:6029-6033.
72. Yip TT, Van de Water J, Gershwin ME, Coppel RL, Hutchens TW. 1996. Cryptic antigenic determinants on the extracellular pyruvate dehydrogenase complex/mimeotope found in primary biliary cirrhosis. J Biol Chem 271: 32825-32833.
73. Zhang L, Wenjie Y, Tian H, Jian Y, Caffrey RE, Dalmasso EA, Fu S, Pham T, Mei J, Ho JJ, Zhang W, Lopez P, Ho DD. 2002. Contribution of human α-defensin 1,2, and 3 to the anti-hiv-1 activity of cd8 antiviral factor. Science 298:995-1000.